Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06422325 · ClinicalTrials.gov registry record · NA
Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT06422325 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 33 participants.
The verdict
NCT06422325, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to test how well a new investigational closed loop system manages your blood sugar with the ability to deliver insulin and pramlintide. Pramlintide is a drug that is used with mealtime insulin to control blood sugar in people who have diabetes. It works by slowing down the movement of food through the stomach which prevents blood sugar from rising too high after a meal. The closed loop system will receive glucose values from the Dexcom G6 continuous glucose monitoring (CGM) and automatically send commands to one Omnipod for insulin and one Omnipod for pramlintide delivery.
Interventions
- DEVICE MPC closed-loop system in insulin only mode
- DEVICE MPC closed-loop system in insulin/pramlintide mode
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2024-07-12 |
| Est. Completion | 2025-01-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06422325
The ClinicalTrials.gov registry entry for NCT06422325 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MPC closed-loop system in insulin only mode is the first listed.
NCT06422325 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06422325 about?
NCT06422325 is a clinical study titled "Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide". The purpose of this study is to test how well a new investigational closed loop system manages your blood sugar with the ability to deliver insulin and pramlintide. Pramlintide is a drug that is used with mealtime insulin to control blood sugar in people who have diabetes. It works by slowing down t...
What is the current status of trial NCT06422325?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2024-07-12. Estimated completion is 2025-01-28.
What interventions are being tested in trial NCT06422325?
The interventions under investigation include: MPC closed-loop system in insulin only mode (DEVICE), MPC closed-loop system in insulin/pramlintide mode (DEVICE).
Who is sponsoring clinical trial NCT06422325?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.